Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INBX

Inhibrx (INBX)

Inhibrx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INBX
DateTimeSourceHeadlineSymbolCompany
11/05/202408:36PR Newswire (US)Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-OffNASDAQ:INBXInhibrx Inc
10/05/202406:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
09/05/202406:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Inc
09/05/202406:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
09/05/202406:37PR Newswire (US)Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated MergerNASDAQ:INBXInhibrx Inc
07/05/202407:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
12/03/202407:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
09/03/202408:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
09/03/202407:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
07/03/202408:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Inc
06/03/202406:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
05/03/202410:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
01/03/202409:26Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:INBXInhibrx Inc
29/02/202401:15PR Newswire (US)Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:INBXInhibrx Inc
29/02/202401:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
29/02/202401:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INBXInhibrx Inc
15/02/202408:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBXInhibrx Inc
07/02/202408:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Inc
27/01/202404:12PR Newswire (US)Kuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to Contact Law FirmNASDAQ:INBXInhibrx Inc
24/01/202409:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Inc
23/01/202422:38Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Inc
23/01/202422:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
23/01/202422:05Dow Jones NewsSanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- UpdateNASDAQ:INBXInhibrx Inc
23/01/202421:40IH Market NewsWall Street Highlights: Vroom Shuts Down Online Car Sales, Ericsson Warns of Decline Outside China, and MoreNASDAQ:INBXInhibrx Inc
23/01/202417:00PR Newswire (US)Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2BNASDAQ:INBXInhibrx Inc
10/11/202308:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
10/11/202308:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBXInhibrx Inc
10/11/202308:00PR Newswire (US)Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:INBXInhibrx Inc
03/11/202300:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
03/11/202300:15PR Newswire (US)Inhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing SarcomaNASDAQ:INBXInhibrx Inc
 Showing the most relevant articles for your search:NASDAQ:INBX